OSCR vs ACGL

For growth investors, Oscar Health, Inc.

(OSCR) is the stronger pick with 27. 5% revenue growth year-over-year, versus 14. 3% for Arch Capital Group Ltd. (ACGL). Arch Capital Group Ltd. (ACGL) offers the better valuation at 8. 1x trailing P/E (10. 0x forward), making it the more compelling value choice. Analysts rate Arch Capital Group Ltd. (ACGL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Arch Capital Group Ltd.

is actually cheaper at 10. 0x.

Over the past 5 years, Arch Capital Group Ltd.

(ACGL) delivered a total return of +146. 7%, compared to -24. 0% for Oscar Health, Inc. (OSCR). Over 10 years, the gap is even starker: ACGL returned +320. 6% versus OSCR's -48. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Arch Capital Group Ltd.

(ACGL) is the lower-risk stock at 0. 02β versus Oscar Health, Inc. 's 1. 84β — meaning OSCR is approximately 11909% more volatile than ACGL relative to the S&P 500. On balance sheet safety, Arch Capital Group Ltd. (ACGL) carries a lower debt/equity ratio of 11% versus 44% for Oscar Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Oscar Health, Inc.

(OSCR) is pulling ahead at 27. 5% versus 14. 3% for Arch Capital Group Ltd. (ACGL). On earnings-per-share growth, the picture is similar: Arch Capital Group Ltd. grew EPS 3. 8% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, OSCR leads at 41. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Arch Capital Group Ltd.

(ACGL) is the more profitable company, earning 22. 1% net margin versus -3. 8% for Oscar Health, Inc. — meaning it keeps 22. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACGL leads at 25. 0% versus -3. 4% for OSCR. At the gross margin level — before operating expenses — ACGL leads at 37. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Arch Capital Group Ltd.

(ACGL) trades at 10. 0x forward P/E versus 29. 8x for Oscar Health, Inc. — 19. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACGL: 10. 5% to $104. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Arch Capital Group Ltd.

(ACGL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02), +320. 6% 10Y return). Oscar Health, Inc. (OSCR) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACGL: +320. 6%, OSCR: -48. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OSCR (Healthcare) and ACGL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OSCR is a small-cap high-growth stock; ACGL is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.